Newsletter
RC: Direct-to-Patient Clinical Trial, a Better term for DCT’s with Jeff Kinglsey, Chair, and CEO of Centricity Research

Outcomes Rocket

RC: Direct-to-Patient Clinical Trial, a Better term for DCT’s with Jeff Kinglsey, Chair, and CEO of Centricity Research

November 22, 2022

RC: Direct-to-Patient Clinical Trial, a Better term for DCT’s with Jeff Kinglsey, Chair, and CEO of Centricity Research

“Decentralized Clinical Trials is a stupid term”; that’s right, we said had had to be said! 

Jeff Kinglsey, Chair, and CEO of Centricity Research speaks of what he loves about working in medical research and shares his opinion on decentralized clinical trials. Healthcare research has evolved a lot during the last two decades, increasingly incorporating technologies that make it easier for patient participation. Jeff explains why Direct-to-Patient Clinical Trial would be a better term for what companies are doing with Decentralized Clinical Trials and gives insights into the benefits and challenges of doing clinical trials in this way.

Tune in and listen to Jeff Kingsley talk about his passion for clinical trials and how he’s working to revolutionize the research industry!

This podcast episode is brought to you by ProofPilot.

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Nashville’s Opportunity: Eco-Action or Anxiety In this excerpt from a Climate x Health Twitter Spaces live chat, experts from Vanderbilt, Oak Ridge National Laboratory, and others discuss hope and want listeners to be energetic and reject “doomerism” while embracing reality and emphasizing teamwork without ego to accomplish individual and systemic goals. This conversation was hosted live from the AAMC conference in Nashville.